Search by Drug Name or NDC

    NDC 00363-0691-12 Aspirin 325 325 mg/1 Details

    Aspirin 325 325 mg/1

    Aspirin 325 is a ORAL TABLET, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is ASPIRIN.

    Product Information

    NDC 00363-0691
    Product ID 0363-0691_f18603d3-aead-4fff-90da-041f483e6576
    Associated GPIs
    GCN Sequence Number 004381
    GCN Sequence Number Description aspirin TABLET DR 325 MG ORAL
    HIC3 H3D
    HIC3 Description ANALGESIC/ANTIPYRETICS, SALICYLATES
    GCN 16720
    HICL Sequence Number 001820
    HICL Sequence Number Description ASPIRIN
    Brand/Generic Generic
    Proprietary Name Aspirin 325
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aspirin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 325
    Active Ingredient Units mg/1
    Substance Name ASPIRIN
    Labeler Name Walgreen Company
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-0691-12 (00363069112)

    NDC Package Code 0363-0691-12
    Billing NDC 00363069112
    Package 1 BOTTLE, PLASTIC in 1 CARTON (0363-0691-12) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
    Marketing Start Date 2017-07-01
    NDC Exclude Flag N
    Pricing Information N/A